Shu-you Peng
- Surgery top 5%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Hepatology top 5%
- Topics
- Pancreatic and Hepatic Oncology Research (29 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers)Hepatocellular Carcinoma Treatment and Prognosis (19 papers)
- Cited by
- HepatologyOncologySurgery
- Journals
- SHILAP Revista de lepidopterologíaCancer LettersWorld Journal of Gastroenterology
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Shu-you Peng
90 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 83
- Surgery 648
- Oncology 487
- Pulmonary and Respiratory Medicine 372
- Molecular Biology 204
- Hepatology 189
Countries citing papers authored by Shu-you Peng
This map shows the geographic impact of Shu-you Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-you Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-you Peng more than expected).
Fields of papers citing papers by Shu-you Peng
This network shows the impact of papers produced by Shu-you Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-you Peng. The network helps show where Shu-you Peng may publish in the future.
Co-authorship network of co-authors of Shu-you Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Shu-you Peng. A scholar is included among the top collaborators of Shu-you Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-you Peng. Shu-you Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 2 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | Mucoepidermoid carcinoma of the pancreas: a case report and a review of literature | 3 |
| 6 | 1 | |
| 7 | [Criteria for radical resection of hilar cholangiocarcinoma]. | 1 |
| 8 | 5 | |
| 9 | 3 | |
| 10 | 6 | |
| 11 | [Mesenchymal stem cells inhibit the expression of CD25 on phytohaemagglutinin-activated lymphocytes]. | 1 |
| 12 | Role of CD97(superscript stalk) and CD55 as Molecular Markers for Prognosis and Therapy of Gastric Carcinoma Patients | 2 |
| 13 | Studies on cellular distribution of elements in human hepatocellular carcinoma samples by molecular activation analysis | 2 |
| 14 | 4 | |
| 15 | [Down-regulated full-length novel gene GDDR and its effect on gastric cancer]. | 30 |
| 16 | [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma]. | 2 |
| 17 | Hypertonic saline solution resuscitation in hemorrhagic shock dogs. | 4 |
| 18 | Experimental study of Anisodamine against hepatic ischemia-reperfusion injury | 1 |
| 19 | 1 | |
| 20 | 1 |
About Shu-you Peng
Shu-you Peng is a scholar working on Hepatology, Oncology and Surgery, having authored 93 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (29 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers) and Hepatocellular Carcinoma Treatment and Prognosis (19 papers). The work is most often cited by research in Hepatology (189 citations), Oncology (487 citations) and Surgery (648 citations). Shu-you Peng has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Chenghong Peng, Jiangtao Li, Xiujun Cai, Yingbin Liu, Yiping Mou, Defei Hong, Xiao Liang, Xiujun Cai, Jianwei Wang and Yulian Wu. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Letters and World Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.